Get Our Top Trade Ideas Delivered Daily - 65% Off Now

+ New Watchlist

Benzinga Research

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

ResMed

RMDNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$238.03

-12.85-5.12%

At Close: -

$238.03

00.00%

After Hours: 5:08 PM EDT

15 minutes delayed

Why is it moving?

ResMed shares are trading lower after Wolfe Research downgraded the stock from Peer Perform to Underperform and announced a $180 price target.

ResMed (RMD) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest news for ResMed (NYSE:RMD) Stock

ResMed Stock (NYSE: RMD)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, September 18, 2024

Stocks Edge Lower As Fed Rate Decision Looms, Treasury Yields Rise As Odds Improve For Smaller Cut: What's Driving Markets Wednesday?
Piero Cingari
ResMed shares are trading lower after Wolfe R...
Benzinga Newsdesk
Needham Reiterates Hold on ResMed
Benzinga Newsdesk
Wolfe Research Downgrades ResMed to Underperf...
Benzinga Newsdesk

Wednesday, September 11, 2024

Reasons to Retain ResMed Stock in Your Portfolio for Now
Zacks

Monday, September 09, 2024

Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
Benzinga Insights
ResMed shares are trading higher. The stock s...
Benzinga Newsdesk
Apple Announces New Sleep Apnea Features On A...
Benzinga Newsdesk

Wednesday, September 04, 2024

A Glimpse Into The Expert Outlook On ResMed Through 6 Analysts
Benzinga Insights
Needham Downgrades ResMed to Hold, Maintains ...
Benzinga Newsdesk

Tuesday, August 27, 2024

Smart Money Is Betting Big In RMD Options
Benzinga Insights

Friday, August 23, 2024

How Is The Market Feeling About ResMed?
Benzinga Insights

Tuesday, August 20, 2024

$1000 Invested In ResMed 10 Years Ago Would Be Worth This Much Today
Benzinga Insights

Monday, August 12, 2024

What's in Store for Cardinal Health in Q4 Earnings?
Zacks

Wednesday, August 07, 2024

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $9,500 Today
Benzinga Insights

Sunday, August 04, 2024

DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
Lekha Gupta

Friday, August 02, 2024

RBC Capital Maintains Sector Perform on ResMe...
Benzinga Newsdesk
ResMed's Q4 Earnings Surpass Estimates, Margins Expand
Zacks
Keybanc Maintains Overweight on ResMed, Raise...
Benzinga Newsdesk
ResMed Earnings Reflect Increased Demand For Sleep Devices, Performance Indicates Positive Dynamics, Opportunities
Vandana Singh
ResMed shares are trading lower. The company ...
Benzinga Newsdesk
Needham Reiterates Buy on ResMed, Maintains $...
Benzinga Newsdesk

Thursday, August 01, 2024

ResMed shares are trading lower. The company ...
Benzinga Newsdesk
ResMed Increases Quarterly Dividend From $0.4...
Benzinga Newsdesk
ResMed Q4 2024 Adj. EPS $2.08 Beats $2.07 Est...
Benzinga Newsdesk

Tuesday, July 30, 2024

ResMed's Options Frenzy: What You Need to Know
Benzinga Insights

Friday, July 26, 2024

If You Invested $1000 In This Stock 20 Years Ago, You Would Have $16,000 Today
Benzinga Insights

Thursday, July 25, 2024

Behind the Scenes of ResMed's Latest Options Trends
Benzinga Insights

Tuesday, July 23, 2024

Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
What 6 Analyst Ratings Have To Say About ResMed
Benzinga Insights
RBC Capital Maintains Sector Perform on ResMe...
Benzinga Newsdesk

Tuesday, July 09, 2024

Looking Into ResMed's Recent Short Interest
Benzinga Insights

Friday, July 05, 2024

Here's Why Staying Invested in Neogen Could be Beneficial
Zacks
Smart Money Is Betting Big In RMD Options
Benzinga Insights

Tuesday, July 02, 2024

$1000 Invested In This Stock 15 Years Ago Would Be Worth $9,600 Today
Benzinga Insights
Is It the Right Time to Hold Labcorp in Your Portfolio?
Zacks

Friday, June 28, 2024

This Is What Whales Are Betting On ResMed
Benzinga Insights
QIAGEN Backs New AAP Guidelines Supporting QFT-Plus Test
Zacks

Thursday, June 27, 2024

Charles River's RMS Growth Aids Amid FX Headwind
Zacks

Wednesday, June 26, 2024

10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights

Tuesday, June 25, 2024

Illumina Rises on Conclusion of GRAIL Divestment
Zacks
Beyond The Numbers: 6 Analysts Discuss ResMed Stock
Benzinga Insights
Oppenheimer Downgrades ResMed to Perform
Benzinga Newsdesk

Monday, June 24, 2024

Abbott's EPD Expansion Continues Despite FX Headwind
Zacks
Why ResMed Shares Are Trading Lower Monday
Dylan Berman
ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday
Avi Kapoor
Semiconductor, Nvidia Woes Deepen; Nasdaq 100 Slips, Dow Rallies; Bitcoin Sinks To $60,400: What's Driving Markets Monday?
Piero Cingari
Citigroup Downgrades ResMed to Neutral
Benzinga Newsdesk
ResMed shares are trading lower following sle...
Benzinga Newsdesk
Nasdaq Futures Slip As Nvidia Sell-Off Continues, S&P 500 Futures Hold Up: Analyst Says 'Valuations Will Go Parabolic And It Will Be A Perfect Time To Sell'
Shanthi Rexaline

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved